Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$19.51 - $27.64 $636,006 - $901,036
-32,599 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$13.77 - $21.66 $581,107 - $914,073
-42,201 Reduced 56.42%
32,599 $697,000
Q4 2020

Feb 16, 2021

SELL
$10.75 - $14.91 $1.54 Million - $2.14 Million
-143,300 Reduced 65.7%
74,800 $1.01 Million
Q3 2020

Nov 04, 2020

BUY
$11.98 - $16.34 $963,192 - $1.31 Million
80,400 Added 58.39%
218,100 $2.76 Million
Q2 2020

Jul 31, 2020

BUY
$10.34 - $15.51 $898,546 - $1.35 Million
86,900 Added 171.06%
137,700 $1.97 Million
Q1 2020

May 08, 2020

SELL
$9.11 - $20.05 $1.06 Million - $2.33 Million
-116,070 Reduced 69.56%
50,800 $648,000
Q4 2019

Feb 11, 2020

BUY
$18.47 - $24.03 $177,312 - $230,688
9,600 Added 6.1%
166,870 $3.42 Million
Q3 2019

Nov 01, 2019

BUY
$21.01 - $28.94 $298,342 - $410,948
14,200 Added 9.93%
157,270 $3.94 Million
Q2 2019

Aug 13, 2019

BUY
$23.33 - $28.3 $1.78 Million - $2.17 Million
76,505 Added 114.93%
143,070 $4.05 Million
Q1 2019

May 13, 2019

SELL
$14.93 - $25.1 $273,219 - $459,330
-18,300 Reduced 21.56%
66,565 $1.63 Million
Q4 2018

Feb 14, 2019

SELL
$12.68 - $19.01 $2.25 Million - $3.37 Million
-177,135 Reduced 67.61%
84,865 $1.33 Million
Q3 2018

Nov 14, 2018

SELL
$13.1 - $16.35 $70,740 - $88,290
-5,400 Reduced 2.02%
262,000 $3.92 Million
Q2 2018

Aug 06, 2018

SELL
$13.65 - $18.7 $43,680 - $59,840
-3,200 Reduced 1.18%
267,400 $3.89 Million
Q1 2018

May 03, 2018

BUY
$14.85 - $24.3 $4.02 Million - $6.58 Million
270,600 New
270,600 $4.3 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.37B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.